Conference preview: LSX World Congress USA 2018

LSX World Congress USA 2018 convenes the best in the business across keynote plenaries, interactive panels, CEO forums, workshops, roundtables, one-to-one partnering and showcase presentations to investors and potential partners.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Europe

EU court under pressure to define SPC limits in patent row

24 April 2026 An opinion has put pressure on the CJEU to clarify a long-running grey area that could change the game for how drug makers secure supplementary protection certificates across Europe.

Americas

Amneal acquires biopharma ahead of $300bn patent wave

23 April 2026 The US pharma giant is spending up to $1 billion to build an end-to-end biosimilar platform and is counting on a decade of expiring biologic patents to make it pay off.

Americas

Health tech firm sues Nvidia-backed rival over ‘brazen’ theft

23 April 2026 Plaintiff alleges that a $6 billion rival probed its records system via a long-term customer, using confidential information to develop its product in the behavioural health tech space.

More features

Amneal acquires biopharma ahead of $300bn patent wave

Health tech firm sues Nvidia-backed rival over ‘brazen’ theft

Squires refuses to resurrect HydraFacial patent review

Litigator from Brown Rudnick moves firms to chair practice

Penile implant maker’s $17m trade secret award unravels

Appeals court eases Teva’s headache with reversal

Cancer drug researcher hit with suit over mutation-targeting tools

Court narrows Mylan’s Copaxone suit but key claims survive

Conference preview: LSX World Congress USA 2018

More on this story

Editor's picks

Editor's picks

More features